Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07448805

Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
University Medical Centre Maribor · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Researchers at the Department of Intensive Internal Medicine and the Department of Endocrinology and Diabetology will conduct a study to verify the accuracy and safety of the new Syai Tag system for continuous glucose monitoring in patients in intensive internal care. Almost 150,000 people in Slovenia have diabetes, so keeping a close eye on blood sugar levels is key to preventing complications. The new sensors for continuous monitoring are available over the counter and certified as medical devices. The study will include at least 100 patients who will need blood sugar monitoring during their stay in the intensive care unit. Each patient will have two small sensors placed on each upper arm to continuously measure their blood sugar levels, but these values will not be visible to medical staff. At the same time, healthcare professionals will perform routine blood sugar measurements, and researchers will then compare the accuracy of both methods. The procedure is safe and painless, and patients will receive the same quality of care as usual.

Conditions

Interventions

TypeNameDescription
DEVICEcontinuous glucose monitorpatients who will be hospitalized in the intensive internal medicine department and will receive CGM for glucose monitoring

Timeline

Start date
2026-02-18
Primary completion
2027-02-15
Completion
2027-05-15
First posted
2026-03-04
Last updated
2026-03-04

Locations

1 site across 1 country: Slovenia

Source: ClinicalTrials.gov record NCT07448805. Inclusion in this directory is not an endorsement.